Unlock instant, AI-driven research and patent intelligence for your innovation.

Cardiac or vascular tissue spheroid

A heart tissue and tissue-type technology, applied in cardiovascular system diseases, tissue regeneration, vascular endothelial cells, etc., can solve problems such as morphological characteristics or mechanical action mode technology has not been found.

Inactive Publication Date: 2015-11-04
SAGA UNIVERSITY +1
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, no technology has been found to construct tissues (such as cardiac muscle, blood vessels, cartilage, valves, etc.) with only cells, so that they have morphological characteristics or mechanical modes of action. It can be said that regenerative medicine is still in the process of development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cardiac or vascular tissue spheroid
  • Cardiac or vascular tissue spheroid
  • Cardiac or vascular tissue spheroid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] (1) Preparation of cells

[0093] (1-1) Preparation of primary cardiomyocytes (rat fetal ventricular cardiomyocytes) (CM) (preplating method)

[0094] The SD (kud: sd) neonatal rats on day 1 to 3 after birth were decapitated, the chest was opened and the heart was removed.

[0095] Wash 3 times with HBSS+ / + (Hank's Balanced Salt Solution (Hank's Balanced Salt Solution), containing Mg, Ca: sigma aldrich) cooled to 4°C, and then wash with HBSS- / - (excluding Mg, Ca) 3 times.

[0096] After removing the atria and great blood vessels so that only the ventricle remained, the ventricle was finely cut with scissors to obtain fragments with a size of 1 mm or less. The finely cut ventricular fragments were placed in 0.1% trypsin solution (Wako Pure Chemical Industries, Ltd.) inHBSS- / -, and left to stand at 4°C for 6 hours.

[0097] Next, 10% FBS (sigma) and DMEM (Low Glucose) containing P / S solution (Wako Pure Chemical Industries, Ltd.) were added to stop the trypsin reaction....

Embodiment 2

[0165] This embodiment is an example of preparing a three-dimensional structure by fusing spheres.

[0166] Spheroid formation of each cell was carried out in the same manner as in Example 1.

[0167] Cardiac tissue spheroids were formed by staining cardiomyocytes with a green fluorescent dye, staining vascular endothelial cells with a red fluorescent dye, and staining fibroblasts with a blue fluorescent dye. Further, the four spheres were fused, and observed after 3 hours, 12 hours, and 24 hours.

[0168] As a result, a vascular network is formed through cooperation of the three types of cells, and at the same time, a beating cardiac tissue-type sphere can be prepared ( Figure 9 ). Such as Figure 9 As shown, it was found that the three types of cells were fused. In addition, the cells undergo some sort of reprogramming, forming a new network of blood vessels.

[0169] When the spheres are fused to each other, the spheres beat in sync.

Embodiment 3

[0171] In this example, various types of spheroids were formed using one type of cells, and a heart tissue formation test was performed when each spheroid was blended.

[0172] Spheroid formation of each cell was carried out in the same manner as in Example 1.

[0173] Three types of spheres formed solely by cardiomyocytes (green), spheroids formed by vascular endothelial cells alone (red), and spheroids formed by fibroblasts alone (blue) were observed after 24 hours.

[0174] show the result in Figure 10 . Such as Figure 10 As shown, three kinds of spheres can be fused.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a method for producing a cardiac tissue spheroid or vascular tissue spheroid formed from a mixture of a myocardial cell or smooth muscle cell and at least one type of cell selected from a vascular endothelial cell and fibroblast, and a three dimensional cardiac tissue structure or three dimensional vascular tissue structure which are characterized by combining or laminating said spheroid.

Description

technical field [0001] The invention relates to a heart and blood vessel tissue type spheroid and a manufacturing method thereof. Background technique [0002] Beginning with the iPS cell (reprogramming) technology of Professor Yamanaka of Kyoto University, who won the Nobel Prize in Medicine and Physiology in 2012, the discovery of tissue stem cells, etc., development and research into clinical applications in recent years have been remarkable. Researches on differentiation efficiency, safety, and purification of stem cell-derived cells are being conducted around the world, aiming at the clinical application of stem cell-derived cells. On the other hand, the development of techniques for constructing tissues, etc. from cells and transplanting them is also an urgent task. [0003] The clinical utilization of cells obtained by these techniques includes directly injecting the cells into organs, or injecting them intravenously or arterially, but it is considered that there are ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/00C12N5/071C12N5/077
CPCC12N5/0697A61L27/3804A61L27/3886A61L27/507A61L2430/20C12N5/0691C12N2502/1323C12N2502/1329C12N2502/28A61P9/00A61K35/33A61K35/34A61K35/44A61L27/3625A61L2300/64
Inventor 野口亮田村忠士中山功一森田茂树野出孝一
Owner SAGA UNIVERSITY